Related Experiment Video
Updated: Oct 28, 2025

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
Published on: September 18, 2020
Crosstalk Between DNA Methylation and Gene Mutations in Colorectal Cancer
Maria Dobre1, Alessandro Salvi2, Iulia Andreea Pelisenco3
1Laboratory of Histopathology and Immunohistochemistry, Victor Babes National Institute of Pathology, Bucharest, Romania.
Abstract:
Colorectal cancer (CRC) is often characterized by mutations and aberrant DNA methylation within the promoters of tumor suppressor genes and proto-oncogenes. The most frequent somatic mutations occur within KRAS and BRAF genes. Mutations of the KRAS gene have been detected in approximately 40% of patients, while mutations in BRAF have been detected less frequently at a rate of 10%. In this study, the DNA methylation levels of 22 candidate genes were evaluated in three types of tissue: mucosal tumoral tissue from 18 CRC patients, normal adjacent tissues from 10 CRC patients who underwent surgical resection, and tissue from a control group of six individuals with normal colonoscopies. A differential methylation profile of nine genes (RUNX3, SFRP1, WIF1, PCDH10, DKK2, DKK3, TMEFF2, OPCML, and SFRP2) presenting high methylation levels in tumoral compared to normal tissues was identified. KRAS mutations (codons 12 or 13) were detected in eight CRC cases, and BRAF mutations (codon 600) in four cases. One of the CRC patients presented concomitant mutations in KRAS codon 12 and BRAF, whereas seven patients did not present these mutations (WT). When comparing the methylation profile according to mutation status, we found that six genes (SFRP2, DKK2, PCDH10, TMEFF2, SFRP1, HS3ST2) showed a methylation level higher in BRAF positive cases than BRAF negative cases. The molecular sub-classification of CRC according to mutations and epigenetic modifications may help to identify epigenetic biomarkers useful in designing personalized strategies to improve patient outcomes.
Insights
Colorectal cancer (CRC) involves gene mutations and DNA methylation. This study identified nine genes with altered methylation in CRC tumors and found specific methylation patterns linked to BRAF mutations, suggesting potential biomarkers for personalized treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Colorectal cancer (CRC) pathogenesis involves genetic mutations (e.g., KRAS, BRAF) and epigenetic alterations like DNA methylation.
- Aberrant DNA methylation in tumor suppressor and proto-oncogene promoters is a hallmark of CRC.
- Understanding these molecular changes is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate DNA methylation profiles in colorectal cancer tissues.
- To correlate methylation patterns with KRAS and BRAF mutation status in CRC patients.
- To identify potential epigenetic biomarkers for CRC sub-classification and personalized treatment.
Main Methods:
- DNA methylation levels of 22 candidate genes were analyzed in tumoral, adjacent normal, and control colon tissues.
- KRAS and BRAF mutations were assessed in 18 CRC patient samples.
- Methylation profiles were compared between different tissue types and mutation statuses.
Main Results:
- A distinct methylation profile of nine genes was identified in CRC tumoral tissues compared to normal tissues.
- KRAS mutations were found in 40% and BRAF mutations in 22% of the evaluated CRC cases.
- Six genes (SFRP2, DKK2, PCDH10, TMEFF2, SFRP1, HS3ST2) exhibited higher methylation in BRAF-mutated CRC cases.
Conclusions:
- Epigenetic modifications, specifically DNA methylation, play a significant role in colorectal cancer development.
- Specific gene methylation patterns are associated with KRAS and BRAF mutations in CRC.
- Molecular sub-classification based on mutations and epigenetic alterations can aid in identifying biomarkers for personalized CRC management.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mismatch Repair
Spontaneous and Induced Mutations
Cancers Originate from Somatic Mutations in a Single Cell

